Phosphodiesterase 4 Inhibitors for the Treatment of COPD

This publication has 12 references indexed in Scilit:

• Suppression of human inflammatory cell function by subtype‐selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B
  British Journal of Pharmacology, 1999
• Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 1999
• Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
  New England Journal of Medicine, 1999
• EUROSCOP, ISOLDE and the Copenhagen City Lung Study
  Thorax, 1999
• Inhibition of tumor necrosis factor-α induced neutrophil apoptosis by cyclic AMP: involvement of caspase cascade
  European Journal of Pharmacology, 1999
• Nicotinamide derivatives as selective inhibitors of PDE4
  Expert Opinion on Therapeutic Patents, 1999
• Phosphodiesterase Isozymes
  American Journal of Respiratory and Critical Care Medicine, 1998
• Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?
  Trends in Pharmacological Sciences, 1997
• Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
  American Journal of Respiratory and Critical Care Medicine, 1997
• Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV versus [³H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret
  Journal of Medicinal Chemistry, 1996